Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.3150
+0.0050 (0.22%)
NASDAQ· Last Trade: Sep 16th, 2:09 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors